The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned
- PMID: 36992251
- PMCID: PMC10052576
- DOI: 10.3390/vaccines11030667
The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected the pediatric oncology population globally. Over the course of 2 years, increasing reports have been made to better understand this entity and its pathologic complications on these patients. The pandemic has allowed healthcare providers, hospital systems, and leading oncologic societies to quickly adapt and formulate new guidelines for the effective understanding, management, and treatment of patients with pediatric malignancy.
Keywords: COVID-19; diagnosis; epidemiology; management; oncology; pediatric.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Jazieh A.R., Akbulut H., Curigliano G., Rogado A., Alsharm A.A., Razis E.D., Mula-Hussain L., Errihani H., Khattak A., De Guzman R.B., et al. Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study. JCO Glob. Oncol. 2020;6:1428–1438. doi: 10.1200/GO.20.00351. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources